[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioharvest Sciences Inc (BHST)

Bioharvest Sciences Inc (BHST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 76,699
  • Shares Outstanding, K 19,616
  • Annual Sales, $ 34,510 K
  • Annual Income, $ -11,140 K
  • EBIT $ -6 M
  • EBITDA $ -4 M
  • 60-Month Beta 0.81
  • Price/Sales 2.19
  • Price/Cash Flow N/A
  • Price/Book 3.29

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.13
  • Number of Estimates 2
  • High Estimate $-0.12
  • Low Estimate $-0.14
  • Prior Year $-0.15
  • Growth Rate Est. (year over year) +13.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.57 +9.80%
on 05/11/26
4.47 -12.21%
on 05/01/26
-0.46 (-10.50%)
since 04/27/26
3-Month
3.57 +9.80%
on 05/11/26
4.84 -19.01%
on 03/16/26
-0.79 (-16.77%)
since 02/27/26
52-Week
3.57 +9.80%
on 05/11/26
12.80 -69.38%
on 10/13/25
-2.33 (-37.28%)
since 05/27/25

Most Recent Stories

More News
Tate & Lyle Expands Collaboration with BioHarvest Sciences to Accelerate Next-Generation Sweetener Innovation

Expanded sweetener molecule development program aims to broaden access to plant-based sweetening solutions tailored to diverse customer food and beverage categories.Vancouver, British Columbia and Rehovot,...

BHST : 3.92 (+0.26%)
BioHarvest Sciences Q1 Earnings Call Highlights

BioHarvest Sciences (NASDAQ:BHST) reported higher first-quarter revenue and reiterated its 2026 outlook as management detailed a broader reorganization around two business lines: its direct-to-consumer...

BHST : 3.92 (+0.26%)
BioHarvest Sciences Reports First Quarter 2026 Financial Results and Provides Business Update

Quarterly revenue up 8% year over year; Annual revenue guidance range remains at $42-$48 million CDMO fragrance and Saffron projects reach successful milestones; First quarter CDMO revenue grew 135% YoY...

BHST : 3.92 (+0.26%)
BioHarvest Sciences Appoints New Head of Business Development for its CDMO Division

Business development appointment is aligned with securing long-term customers for development and manufacturing partnershipsVancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 13, 2026)...

BHST : 3.92 (+0.26%)
BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications

- CDMO program advances to Stage 2 of development agreement valued at $1.125 million-Advancement of sustainable solution for the production of saffron, one of the world's most valuable and health-promoting...

BHST : 3.92 (+0.26%)
BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform

Source plant is widely regarded as one of the most valuable fragrance raw materials in the worldStage 2 contract follows successful Stage 1 completion in March 2026Vancouver, British Columbia and Rehovot,...

BHST : 3.92 (+0.26%)
BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - April 30, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its proprietary...

BHST : 3.92 (+0.26%)
BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy

Ilan Sobel joins Board of Directors with focused mandate on D2C growth.Dr. Zaki Rakib, Co-Founder and Executive Chairman, assumes role of Chief Executive Officer, Integrating R&D, Manufacturing, and Operations...

BHST : 3.92 (+0.26%)
BioHarvest Sciences Reports Fourth Quarter and Full-Year 2025 Financial Results

FY2025 Revenues were $34.5 million, up 37% vs previous year.The VINIA brand has achieved the No.1 resveratrol polyphenol position in the United States Market*.Successful 4Q2025 Institutional-led Financing...

BHST : 3.92 (+0.26%)
BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform

CDMO division has successfully completed Stage 1 under a development contractVancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 31, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST)...

BHST : 3.92 (+0.26%)

Business Summary

BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based...

See More

Key Turning Points

3rd Resistance Point 4.07
2nd Resistance Point 4.03
1st Resistance Point 3.98
Last Price 3.92
1st Support Level 3.89
2nd Support Level 3.85
3rd Support Level 3.80

See More

52-Week High 12.80
Fibonacci 61.8% 9.27
Fibonacci 50% 8.19
Fibonacci 38.2% 7.10
Last Price 3.92
52-Week Low 3.57

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.